BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 36834617)

  • 1. Is Hormone Replacement Therapy a Risk Factor or a Therapeutic Option for Alzheimer's Disease?
    Mills ZB; Faull RLM; Kwakowsky A
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hormone replacement therapy to maintain cognitive function in women with dementia.
    Hogervorst E; Yaffe K; Richards M; Huppert F
    Cochrane Database Syst Rev; 2002; (3):CD003799. PubMed ID: 12137718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of estrogen therapy on Alzheimer's disease: a fork in the road?
    Brinton RD
    CNS Drugs; 2004; 18(7):405-22. PubMed ID: 15139797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
    Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
    Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The estrogen myth: potential use of gonadotropin-releasing hormone agonists for the treatment of Alzheimer's disease.
    Casadesus G; Garrett MR; Webber KM; Hartzler AW; Atwood CS; Perry G; Bowen RL; Smith MA
    Drugs R D; 2006; 7(3):187-93. PubMed ID: 16752944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis.
    Hogervorst E; Williams J; Budge M; Riedel W; Jolles J
    Neuroscience; 2000; 101(3):485-512. PubMed ID: 11113299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause and mitochondria: windows into estrogen effects on Alzheimer's disease risk and therapy.
    Henderson VW; Brinton RD
    Prog Brain Res; 2010; 182():77-96. PubMed ID: 20541661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research.
    Henderson VW
    Neuroscience; 2006; 138(3):1031-9. PubMed ID: 16310963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex, hormones, and Alzheimer's disease.
    Baum LW
    J Gerontol A Biol Sci Med Sci; 2005 Jun; 60(6):736-43. PubMed ID: 15983176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive health after menopause: Does menopausal hormone therapy affect it?
    Stute P; Wienges J; Koller AS; Giese C; Wesemüller W; Janka H; Baumgartner S
    Best Pract Res Clin Endocrinol Metab; 2021 Dec; 35(6):101565. PubMed ID: 34538724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is there a role for estrogen replacement therapy in the prevention and treatment of dementia?
    Birge SJ
    J Am Geriatr Soc; 1996 Jul; 44(7):865-70. PubMed ID: 8675940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.
    Henderson VW
    J Steroid Biochem Mol Biol; 2014 Jul; 142():99-106. PubMed ID: 23727128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hormonal replacement therapy and Alzheimer's disease. All quiet on the western front?].
    Ancelin ML; Berr C
    Psychol Neuropsychiatr Vieil; 2003 Dec; 1(4):251-7. PubMed ID: 15683960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone replacement therapy is associated with improved cognition and larger brain volumes in at-risk APOE4 women: results from the European Prevention of Alzheimer's Disease (EPAD) cohort.
    Saleh RNM; Hornberger M; Ritchie CW; Minihane AM
    Alzheimers Res Ther; 2023 Jan; 15(1):10. PubMed ID: 36624497
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The menopause and HRT. HRT and cognitive decline.
    Maki P; Hogervorst E
    Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):105-22. PubMed ID: 12763515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone replacement therapy and breast cancer: revisiting the issues.
    DeGregorio MW; Taras TL
    J Am Pharm Assoc (Wash); 1998; 38(6):738-44; quiz 744-6. PubMed ID: 9861792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can estrogen play a significant role in the prevention of Alzheimer's disease?
    Kesslak JP
    J Neural Transm Suppl; 2002; (62):227-39. PubMed ID: 12456066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dementia: risk and protective factors with special consideration of gender and hormone replacement therapy].
    Stoppe G
    Z Arztl Fortbild Qualitatssich; 2000 Apr; 94(3):217-22. PubMed ID: 10802897
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.